文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

常规凝血试验对热射病患者预后的预测价值

The prognostic value of routine coagulation tests for patients with heat stroke.
PubMed 文献 · Am J Emerg Med · 2020-04-22
一句话结论热射病发病24小时内PT-INR≥1.7和APTT≥51.45是60天死亡的独立预后因素,30分钟内降温至38.9°C者凝血指标更低。

这项多中心回顾性研究纳入发病24小时内到院的热射病患者,评估常规凝血指标的预后价值。60天死亡率为20.9%。死亡患者PT-INR和APTT中位数均显著高于存活者(P<0.01)。Cox回归显示60天死亡率与PT-INR(P=0.032)和APTT(P=0.004)相关。预测60天死亡的最佳PT-INR界值为1.7,最佳APTT界值为51.45。PT-INR≥1.7和APTT≥51.45者生存时间显著缩短。30分钟内体温降至38.9°C者24小时内PT-INR和APTT水平显著低于降温更慢者。

要点

  • 热射病患者发病24小时内PT-INR≥1.7是60天死亡的独立预后因素(Cox回归P=0.032),生存时间显著缩短。
  • 热射病患者发病24小时内APTT≥51.45是60天死亡的独立预后因素(Cox回归P=0.004),生存时间显著缩短。
  • 以PT-INR≥1.7和APTT≥51.45各计1分的预后评分有助于预测热射病60天死亡率。
  • 30分钟内体温降至38.9°C的热射病患者,24小时内PT-INR和APTT水平显著低于降温更慢者。
  • 该研究60天死亡率为20.9%,死亡患者PT-INR和APTT中位数均显著高于存活者(P<0.01)。

适用人群与场景

  • 发病24小时内到达医院的热射病患者。

诊断标准与关键阈值

  • 预测60天死亡的最佳PT-INR界值为1.7。
  • 预测60天死亡的最佳APTT界值为51.45。
  • 预后评分:PT-INR≥1.7计1分,APTT≥51.45计1分。

研究设计与关键结果

  • 多中心回顾性研究,纳入发病24小时内到院的热射病患者,检测发病24小时内常规凝血指标包括最低血小板计数。
  • 60天死亡率为20.9%。
  • 死亡患者PT-INR中位数显著高于存活者(P<0.01),死亡患者APTT中位数显著高于存活者(P<0.01)。
  • Cox回归显示60天死亡率与PT-INR(P=0.032)和APTT(P=0.004)相关。
  • PT-INR≥1.7者总体生存时间显著缩短(P<0.01)。
  • APTT≥51.45者生存时间也缩短(P<0.01)。
  • 以PT-INR≥1.7和APTT≥51.45各计1分的预后评分有助于预测60天死亡率。
  • 30分钟内体温降至38.9°C者24小时内PT-INR和APTT水平显著低于降温更慢者。

证据类型、等级与局限

  • 证据类型:多中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对发病24小时内到院的热射病患者,可检测PT-INR和APTT以辅助评估60天死亡风险,PT-INR≥1.7和APTT≥51.45提示预后不良。
  • 作者认为PT-INR≥1.7和APTT≥51.45各计1分的预后评分有助于预测热射病60天死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the prognostic value of routine coagulation tests for patients with heat stroke.

METHODS: This was a multi-center retrospective study. Patients who arrived at the hospital <24 h after the onset of Heat Stroke (HS) were included. The routine coagulation variables were detected within 24 h after the onset, including the lowest platelet count (PLC).

RESULTS: 60-day mortality rate was 20.9%. The median Prothrombin Time-International Normalized Ratio (PT-INR) of the non-surviving patients was significantly higher than that of the survivors (P < 0.01). The median Activated Partial Thromboplastin Time (APTT) in non-surviving patients was significantly higher than in the surviving patients (P < 0.01). A Cox regression analysis revealed that 60-day mortality was associated with PT-INR (P = 0.032) and APTT (P = 0.004). The optimal PT-INR point for predicting 60-day mortality rate was 1.7. The optimal APTT point for predicting 60-day mortality was 51.45. Patients with increased PT-INR (≥1.7) levels had, overall, a significantly reduced survival time (P < 0.01). Patients with elevated APTT (≥51.45) also had a decrease in survival time (P < 0.01). The prognostic scoring, with increased PT-INR (≥1.7) and prolonged APTT (≥51.45) at one point each, was also demonstrated to be useful in predicting 60-day mortality. Patients whose temperature fell to 38.9 °C within 30 min had significantly lower levels of PT-INR and APTT within 24 h than those who took longer to cool down.

CONCLUSIONS: A prolonged APTT and elevated PT-INR within 24 h are independent prognostic factors of 60-day mortality in HS.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Xing L, Liu SY, Mao HD, et al. The prognostic value of routine coagulation tests for patients with heat stroke. Am J Emerg Med. 2020. PMID: 32389399. doi:10.1016/j.ajem.2020.04.062

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。